Amneal Pharmaceuticals (AMRX) Profit After Tax (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Profit After Tax of $62.3 million for Q1 2026, up 410.5% year-over-year from $12.2 million in Q1 2025, and up 25.58% quarter-over-quarter from $49.6 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Profit After Tax (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Profit After Tax history runs 10 years deep, the most recent figure standing at $62.3 million for Q1 2026.
- In Q1 2026, Profit After Tax rose 410.5% year-over-year to $62.3 million; the TTM figure through Mar 2026 stood at $136.6 million (up 504.11% YoY), while the FY2025 annual figure was $127.9 million, up 209.45% from the prior year.
- Profit After Tax for Q1 2026 stood at $62.3 million, up from $49.6 million in the prior quarter.
- The five-year high for Profit After Tax was $62.3 million in Q1 2026, with the low at -$240.1 million in Q2 2022.
- The 5-year median for Profit After Tax is $3.8 million (2022), against an average of -$18.1 million.
- The sharpest annual moves came in 2023 and 2026: Profit After Tax slumped 2717.38% in 2023, then surged 410.5% in 2026.
- Amneal Pharmaceuticals' Profit After Tax stood at $3.8 million in 2022, then plunged by 2717.38% to -$98.6 million in 2023, then jumped by 35.37% to -$63.8 million in 2024, then surged by 177.76% to $49.6 million in 2025, then advanced by 25.58% to $62.3 million in 2026.
- Business Quant data shows AMRX's Profit After Tax at $62.3 million in Q1 2026, $49.6 million in Q4 2025, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.69 Bn | 5.56 Bn | 334.51 Mn | 69.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69.61 Mn |
| Mar 31, 2026 | 62.26 Mn |
| Dec 31, 2025 | 49.57 Mn |
| Sep 30, 2025 | 2.37 Mn |
| Jun 30, 2025 | 22.42 Mn |
| Mar 31, 2025 | 12.20 Mn |
| Dec 31, 2024 | -63.75 Mn |
| Sep 30, 2024 | 11.76 Mn |
| Jun 30, 2024 | 5.99 Mn |
| Mar 31, 2024 | -91.64 Mn |
| Dec 31, 2023 | -98.65 Mn |
| Sep 30, 2023 | 9.68 Mn |
| Jun 30, 2023 | 29.68 Mn |
| Mar 31, 2023 | -6.94 Mn |
| Dec 31, 2022 | 3.77 Mn |
| Sep 30, 2022 | -7.61 Mn |
| Jun 30, 2022 | -240.08 Mn |
| Mar 31, 2022 | -8.82 Mn |
| Dec 31, 2021 | -20.46 Mn |
| Sep 30, 2021 | -6.09 Mn |